Update on Guidance on Reporting COVID-19 Vaccines

Texas Health and Human Services Commission sent this bulletin at 12/14/2023 08:15 AM CST / Este e-mail ha sido enviado por Texas Health and Human Services Commission el 12/14/2023 08:15 AM CST

DSHS Logo

 

Overview:

Providers can no longer report de-authorized COVID-19 vaccines in ImmTrac2 and will now receive an error message upon attempting to do so. Please share this communication with your IT staff and Electronic Health Record vendors for their awareness.

Update on Reporting COVID-19 Vaccines in ImmTrac2:

In 2023 the Food and Drug Administrations (FDA) de-authorized some COVID-19 vaccines. The expiration date for these COVID-19 vaccines is listed in the table below. Providers can no longer report administration of COVID-19 vaccines (new or historical) after their end date in ImmTrac2.

Unauthorized trade names and corresponding end dates in ImmTrac2:

 

Tradename

CVX Code

CPT Code

End Date

Pfizer COVID-19 Vaccine 

208 

91300 

4/18/2023 

Spikevax 100mcg/0.5mL 

207 

-

4/18/2023 

Moderna COVID-19 Vaccine 

207 

91301 and 91306

4/18/2023 

COMIRNATY TS, 30mcg/0.3mL 

217 

91305 

4/18/2023 

COMIRNATY TS, 10mcg/0.2mL 

218 

91307 

4/18/2023 

COMIRNATY TS, 3mcg/0.2mL 

219 

91308 

4/18/2023 

Moderna COVID-19 Pedi 6-11yrs) 

221 

91309 

4/18/2023 

Moderna COVID-19 Pedi (6mos-5yrs) 

228 

91311 

4/18/2023 

Janssen COVID-19 Vaccine

212 

91303 

6/20/2023 

Moderna Bivalent 

229 

91313 and 91314 

9/11/2023 

Moderna Bivalent Booster (6mos-5yrs) 

230 

91316 

9/11/2023 

Pfizer bivalent 12+ 

300 

91312

9/11/2023 

Pfizer Bivalent Peds (5-11yrs) 

301 

91315 

9/11/2023 

Pfizer Bivalent Booster    

(6mos-4yrs) 

302 

 -

9/11/2023 

Novavax COVID-19 Vaccine 

211 

91304 

10/3/2023 

Currently authorized tradenames accepted in ImmTrac2:

Tradename

CVX Code

CPT Code

Pfizer (6mos-4yrs) (2023-24 Formula)

308

91318

Pfizer (5-11yrs) (2023-24 Formula)

310

91319

Comirnaty 12+(2023-24 Formula)

309

91320

Moderna (6mos-11yrs) (2023-24 Formula)

311

91321

Spikevax 12+ (2023-24 Formula)

312

91322

Novavax 12+ (2023-24 Formula)

313

91304

 

Impact of the Change:  

 

A. Providers reporting through ImmTrac2 user interface:

If a provider reports administration of a COVID-19 vaccine after the vaccine end date, they will receive a warning message and the immunization will not be accepted. See Figure 1.

 

Figure 1

 

Figure 1: Display of warning message “Validation Errors”

 

B. Providers reporting through data exchange:

If a provider reports administration of a COVID-19 vaccine after the vaccine end date, they will receive the following rejection errors:

  • For COVID-19 Monovalent vaccines revoked on April 18, 2023:
    IMR-139::Record rejected. Invalid administration date. This vaccine (Vaccine Name: COVID-19 mRNA, LNP-S, bival, PF,50mcg/0.5 mL) is not authorized for administration by FDA after Mon Sep 11 00:00:00 CDT 2023.
  • For COVID-19 Bivalent vaccines revoked on September 11, 2023:
    IMR-139::Record rejected. Invalid administration date. This vaccine (Vaccine Name: COVID-19 mRNA, LNP-S, bival, PF,50mcg/0.5 mL) is not authorized for administration by FDA after Mon Sep 11 00:00:00 CDT 2023.

 

Questions?   

For questions related to this communication, contact: